12.01.2017 • NewsAzelisBiocidesDistribution Agreement

Lonza Extends Its Distribution Relationship with Azelis

© Azelis
© Azelis

Lonza expanded its distribution agreement with Azelis in Europe with effect from Jan. 1, 2017. The company will offer Lonza’s materials protection ingredients to industrial market segments such as paints, coatings, inks, emulsion polymerisation, adhesives and sealants, marine paints, building products, construction auxiliaries and mineral slurries. The new mandate covers Germany, Switzerland, United Kingdom, Benelux, Bulgaria, Slovenia, Croatia, Serbia and Ukraine. Azelis has already been serving Lonza in France and Italy for more than ten years and in Turkey since 2015.

Per Westin, head of Global Sales, Coatings & Composites SBU Lonza, comments: “We chose Azelis because of their ability to offer customer service and satisfaction through experience, knowledge of the products and applications and their approach to product stewardship and regulatory compliance. We are looking forward to working with Azelis in this expanded partnership.”

To support the development of its biocide business, Azelis has hired Gilles Pradier as business development manager for this segment. Pradier is a biocide specialist with over 20 years’ experience in marketing and sales of industrial biocides. He will be based in the Azelis Paris office.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read